Sanofi, Regeneron win FDA nod for Dupixent in chronic hives
FDA moves to block biopharma employees from serving on advisory committees
A big moment is coming for psychedelics
How a scrapped Pfizer drug became a winner for SpringWorks
*please scroll down for all the latest news *
